-+ 0.00%
-+ 0.00%
-+ 0.00%

Regenxbio plans USD 100 million follow-on common stock offering

PUBT·07/16/2026 20:29:50
Listen to the news
Regenxbio plans USD 100 million follow-on common stock offering
  • Regenxbio launched an underwritten public offering of USD 100 million of common stock, subject to market conditions.
  • Underwriters received a 30-day option to buy up to 15% more shares.
  • Morgan Stanley, J.P. Morgan, Leerink Partners, Mizuho named joint bookrunners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenxbio Inc. published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.